Click sobre imagen para ampliar
The goal of this study is to shed light on the motivations and experiences of whistle-blowers in cases of major health care fraud. We conducted interviews with whistle-blowers who were key informants in recent prosecutions brought against pharmaceutical manufacturers. Enforcement actions against pharmaceutical manufacturers have become the most lucrative type of health care fraud litigation on the basis of recovery amounts (average and gross).
Más...
jueves, 3 de junio de 2010
Wistle-Blowers´ Experiences in Fraud Litigation against Pharmaceutical Companies
Etiquetas:
AZ,
Bayer,
BMS,
Glaxo,
Investigación,
Lilly,
Merck,
Schering Ploug,
USA
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario